Lilly Expands Its Pharm-to-Table Offering, Promotes a Lower Price for Consistent Use
Shares:
After a chill week, we’re back to drinking from the firehose. One of the larger, if not sufficiently heralded, wins for the patient advocacy community last year was the effort
It’s kind of a slow day today, which has me thinking ahead to the J.P. Morgan Health Care conference in January. My thoughts are swirling around a couple of things:
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv